c1q receptor therapeutics (Alpha-Beta)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namec1q receptor therapeutics (Alpha-Beta)
Drug Alias Namecomplement 1q receptor modulator(Alpha-Beta)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionComplement C1q subcomponent modulators
TargetsComplement C1q subcomponent
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlpha-Beta Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlpha-Beta Technology
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A